Ascendia Pharma
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
661 Us Hwy 1 Unit B, North Brunswick, Ne...Phone Number
(732) 640-0058Website
www.ascendiapharma.comRevenue
$126.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Ascendia Pharma
Ascendia Pharma is a specialty pharmaceutical company dedicated to developing enhanced formulations of existing drug products, and enabling formulations for pre-clinical and clinical stage drug candidates. Established in 2012, Ascendia Pharma is is headquartered in New Jersey, United States.Explore more
Popular SearchesAscendia Pharmaceuticals IncAscendia Pharmaceuticals LLCAscendia PharmaceuticalsAscendia Brands IncAscendia Brands Co. IncSIC Code 28,283NAICS Code 32,325Show moreAscendia Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ascendia Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ascendia Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ascendia Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Ascendia Pharma
Check out if Ascendia Pharma is spiking on competitors!
Click to see if Ascendia Pharma had a recent Job posting/layoffs
Check if Ascendia Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ascendia Pharma has new funding data
Earning: See what the market has to say on Ascendia Pharma recently announced quarterly report
Recommended Actions
Find VP level buyers at Ascendia Pharma
Find 3 more new buyers
Compare Similar Companies to Ascendia Pharma
Compare insights from companies similar to Ascendia Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ascendia Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ascendia Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ascendia Pharma.
Ascendia Pharma financials insights
Gather financial insights about Ascendia Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Ascendia Pharma Tech Stack
A closer look at the technologies used by Ascendia Pharma
Most Recent Scoops
Event
Product Marketing, Events, Sales, Compliance, Logistics / Supply Chain, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Engineering, Automation, Sales, Software, Logistics / Supply Chain, Bioengineering, Pharmaceuticals, Field /Outside Sales, Field Marketing, Healthcare Technology, Manufacturing Operations, Operations
Event
Events
Award
Award
Event
Ascendia Pharma News & Media
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
ENGLEWOOD, Colo., Oct. 5, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced that it has...Ascendia® Named to 2023 Inc. 5000 List of America's Fastest-Growing Private Companies for the Fourth Consecutive Year
— Leading Specialty Pharma CDMO Continues Strong Growth Trend Due to Making the Impossible Possible for Pharmaceutical and Biological Companies – NORTH BRUNSWICK, N.J., Aug. 24, 2023 /PRNewswire/ -- Ascendia Pharmaceuticals®, a leading specialty pharmaceutical contract development and...Ascendia Pharmaceuticals Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval
— Leading Specialty CDMO Partners with AcuteBio, LLC to Create a Breakthrough 505(b)(2) Nanomedicine to Improve Acute Care Treatment Modalities with a Gold Standard Medication — NORTH BRUNSWICK, N.J., June 27, 2023 /PRNewswire/ -- Ascendia Pharmaceuticals CEO Jim Huang, Ph.D. announces...Ascendia Pharmaceuticals Named to Inc. 5000 List of America's Fastest-growing Private Companies for Third Consecutive Year
— Leading Specialty CDMO's Continued Growth Recognized by Prominent Business Media Property — NORTH BRUNSWICK, N.J., Sept. 8, 2022 /PRNewswire/ -- Ascendia Pharmaceuticals announces it has been named to the prestigious Inc. 5000 rankings of the fastest growing privately-owned companies in...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ascendia Pharma
Sign Up For FreeTo access detailed company insights
Ascendia Pharma is a specialty pharmaceutical company dedicated to developing enhanced formulations of existing drug products, and enabling formulations for pre-clinical and clinical stage drug candidates. Established in 2012, Ascendia Pharma is is headquartered in New Jersey, United States.... Read More
